| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.09 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |